Ryan & Maniskas, LLP Announces Investigation of Pharmaceutical Product Development Inc.
October 04 2011 - 6:03PM
Business Wire
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/ppdi) is
investigating potential claims against the board of directors of
Pharmaceutical Product Development Inc. ("PPD" or the "Company")
(NASDAQ: PPDI) concerning possible breaches of fiduciary duty and
other violations of law related to the Company’s efforts to sell
PPD to by an affiliate of The Carlyle Group and Hellman &
Friedman in a transaction valued at approximately $3.9 billion.
Our investigation concerns possible breaches of fiduciary duty
and other violations of law related to the approval of the
transaction by Company’s board of directors; in particular, whether
the Company undertook a fair process to obtain fair consideration
for all shareholders of PPD. For more information regarding our
investigation, please contact Ryan & Maniskas, LLP (Richard A.
Maniskas, Esquire) toll-free at (877) 316-3218 or by email at
rmaniskas@rmclasslaw.com or visit:
www.rmclasslaw.com/cases/ppdi.
Under the terms of the definitive agreement, PPD shareholders
will receive $33.25 in cash for each share of PPD common stock they
own.
If you own shares of PPD and would like to learn more about
these claims or if you wish to discuss these matters and have any
questions concerning this announcement or your rights, contact
Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign
up online, visit: www.rmclasslaw.com/cases/ppdi. You may also email
Mr. Maniskas at rmaniskas@rmclasslaw.com. For more information
about class action cases in general, please visit our website:
www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide.
Pharmaceutical Product Developme (NASDAQ:PPDI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pharmaceutical Product Developme (NASDAQ:PPDI)
Historical Stock Chart
From Apr 2023 to Apr 2024
